• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医院是否是 COVID19 传播的中心?来自印度南部一家三级医院的医护人员连续血清学调查的结果。

Are hospitals epicentres of COVID19 transmission? Findings of serial serosurveys among healthcare workers from a tertiary hospital in South India.

机构信息

Department of Microbiology, Bangalore Baptist Hospital, Bangalore, Karnataka, 560024, India.

Division of Community Health and Family Medicine, Bangalore Baptist Hospital, Bangalore, Karnataka, 560024, India.

出版信息

Indian J Med Microbiol. 2022 Jan-Mar;40(1):141-143. doi: 10.1016/j.ijmmb.2021.10.006. Epub 2021 Nov 10.

DOI:10.1016/j.ijmmb.2021.10.006
PMID:34774341
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8579239/
Abstract

We conducted a serial cross-sectional study and used blood bank donors serosurvey and the ICMR serosurvey reports for comparison. Seroprevalence was 0% among HCWs (n-211) and blood bank donors (n-210) during the first phase while ICMR serosurvey reported 0.5% among general population in the district at the same time. In phase 2, we estimated a seroprevalence of 9.2% as compared to 18.8% among general population. Seroprevalence among HCWs was comparable to that of the general population during both phases. We postulate that good infection control policies and practice can provide safe working environment without additional risk to HCWs.

摘要

我们进行了一项连续的横断面研究,并将血库献血者的血清学调查结果与 ICMR 的血清学调查结果进行了比较。在第一阶段,医护人员(n=211)和血库献血者(n=210)的血清阳性率均为 0%,而 ICMR 同期在该地区的一般人群中的血清阳性率为 0.5%。在第二阶段,与一般人群的 18.8%相比,我们估计的血清阳性率为 9.2%。在两个阶段,医护人员的血清阳性率与一般人群相当。我们推测,良好的感染控制政策和实践可以为医护人员提供安全的工作环境,而不会带来额外的风险。

相似文献

1
Are hospitals epicentres of COVID19 transmission? Findings of serial serosurveys among healthcare workers from a tertiary hospital in South India.医院是否是 COVID19 传播的中心?来自印度南部一家三级医院的医护人员连续血清学调查的结果。
Indian J Med Microbiol. 2022 Jan-Mar;40(1):141-143. doi: 10.1016/j.ijmmb.2021.10.006. Epub 2021 Nov 10.
2
A cross-sectional study of SARS-CoV-2 seroprevalence among asymptomatic healthcare workers in a tertiary healthcare centre: Assessing the impact of PPE guidelines.横断面研究:三级保健中心无症状医护人员中 SARS-CoV-2 血清流行率:评估 PPE 指南的影响。
Indian J Med Microbiol. 2021 Oct-Dec;39(4):528-533. doi: 10.1016/j.ijmmb.2021.09.011. Epub 2021 Oct 20.
3
SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020-January 2021.2020 年 12 月至 2021 年 1 月期间印度普通人群和医护人员中的 SARS-CoV-2 血清流行率。
Int J Infect Dis. 2021 Jul;108:145-155. doi: 10.1016/j.ijid.2021.05.040. Epub 2021 May 19.
4
Cross-sectional prevalence of SARS-CoV-2 antibodies in healthcare workers in paediatric facilities in eight countries.八个国家儿科医疗机构医护人员中 SARS-CoV-2 抗体的横断面患病率。
J Hosp Infect. 2021 Apr;110:60-66. doi: 10.1016/j.jhin.2020.12.019. Epub 2021 Jan 7.
5
SARS-CoV-2 Seroprevalence Among Healthcare Workers by Workplace Exposure Risk in Kashmir, India.印度克什米尔地区不同工作场所暴露风险的医护人员中 SARS-CoV-2 血清流行率。
J Hosp Med. 2021 May;16(5):274-281. doi: 10.12788/jhm.3609.
6
Longitudinal assessment of SARS-CoV-2 IgG seroconversionamong front-line healthcare workers during the first wave of the Covid-19 pandemic at a tertiary-care hospital in Chile.智利一家三级医院在新冠疫情第一波期间对一线医护人员的 SARS-CoV-2 IgG 血清阳转进行的纵向评估。
BMC Infect Dis. 2021 May 26;21(1):478. doi: 10.1186/s12879-021-06208-2.
7
Higher rate of SARS-CoV-2 IgG seropositivity in hospital-based healthcare workers compared to elderly care staff in a Swedish low-prevalence region: a cross-sectional study.在瑞典低流行地区,与老年护理人员相比,医院医护人员的 SARS-CoV-2 IgG 血清阳性率更高:一项横断面研究。
Infect Dis (Lond). 2021 Nov-Dec;53(12):920-929. doi: 10.1080/23744235.2021.1959949. Epub 2021 Aug 5.
8
The role of supporting services in driving SARS-CoV-2 transmission within healthcare settings: A multicenter seroprevalence study.支持性服务在医疗机构内推动新冠病毒传播中的作用:一项多中心血清流行率研究。
Int J Infect Dis. 2021 Jun;107:257-263. doi: 10.1016/j.ijid.2021.04.071. Epub 2021 Apr 27.
9
Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India.印度医护人员中 SARS-CoV-2 抗体的血清阳性率及其对感染控制实践的影响。
Indian J Med Res. 2021;153(1 & 2):207-213. doi: 10.4103/ijmr.IJMR_3911_20.
10
SARS-COV-2 seroprevalence among all healthcare workers in a tertiary hospital in Spain.西班牙一家三级医院所有医护人员中 SARS-CoV-2 的血清流行率。
Infect Dis (Lond). 2022 Jan;54(1):8-15. doi: 10.1080/23744235.2021.1963468. Epub 2021 Aug 23.

本文引用的文献

1
The burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population: Results from a statewide sentinel-based population survey in Karnataka, India.印度卡纳塔克邦全州基于哨点的人群调查:普通人群中 SARS-CoV-2 感染和 IgG 抗体的负担。
Int J Infect Dis. 2021 Jul;108:27-36. doi: 10.1016/j.ijid.2021.05.043. Epub 2021 May 21.
2
Serology surveillance of SARS-CoV-2 antibodies among healthcare workers in COVID-19 designated facilities in Malaysia.马来西亚新冠肺炎定点医疗机构医护人员中新冠病毒2型抗体的血清学监测。
Lancet Reg Health West Pac. 2021 Apr;9:100123. doi: 10.1016/j.lanwpc.2021.100123. Epub 2021 Mar 21.
3
Seroprevalence to SARS-CoV-2 Among Healthcare Workers in an Exclusive Pediatric Hospital.一家专科医院中医护人员对新冠病毒的血清阳性率
Indian Pediatr. 2021 Mar 15;58(3):279-280. doi: 10.1007/s13312-021-2170-1.
4
SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey.2020 年 8 月至 9 月印度 SARS-CoV-2 抗体血清阳性率:第二次全国家庭血清学调查结果。
Lancet Glob Health. 2021 Mar;9(3):e257-e266. doi: 10.1016/S2214-109X(20)30544-1. Epub 2021 Jan 27.
5
Prevalence and socio-demographic factors of SARS-CoV-2 antibody in multi-ethnic healthcare workers.多民族医护人员中 SARS-CoV-2 抗体的流行情况及社会人口学因素。
Clin Med (Lond). 2021 Jan;21(1):e5-e8. doi: 10.7861/clinmed.2020-0619.
6
Seroprevalence of COVID-19 Amongst Health Care Workers in a Tertiary Care Hospital of a Metropolitan City from India.印度一座大城市的三级护理医院医护人员中新冠病毒病的血清流行率
J Assoc Physicians India. 2020 Nov;68(11):14-19.
7
Prevalence of COVID-19 antibodies in healthcare workers at the peak of the pandemic in Mumbai, India: A preliminary study.印度孟买疫情高峰期医护人员中新冠病毒抗体的流行情况:一项初步研究。
Indian J Med Microbiol. 2020 Jul-Dec;38(3 & 4):461-463. doi: 10.4103/ijmm.IJMM_20_308.
8
Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison.五种 SARS-CoV-2 免疫测定法的性能特征:头对头基准比较。
Lancet Infect Dis. 2020 Dec;20(12):1390-1400. doi: 10.1016/S1473-3099(20)30634-4. Epub 2020 Sep 23.
9
Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020.2020 年 5 月至 6 月印度全国血清学调查的 SARS-CoV-2 感染流行率。
Indian J Med Res. 2020;152(1 & 2):48-60. doi: 10.4103/ijmr.IJMR_3290_20.
10
Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare workers with differing levels of coronavirus disease 2019 (COVID-19) patient exposure.不同程度接触 2019 年冠状病毒病(COVID-19)患者的医护人员中严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)抗体的血清阳性率。
Infect Control Hosp Epidemiol. 2020 Dec;41(12):1441-1442. doi: 10.1017/ice.2020.390. Epub 2020 Aug 3.